Percutaneous cystic duct stent placement for the treatment of acute cholecystitis resulting from common bile duct stent placement for malignant obstruction.
Common bile duct (CBD) stent placement to relieve malignant biliary obstruction can occasionally cause cystic duct obstruction and acute cholecystitis. Cholecystostomy tube placement is often performed in patients with limited life expectancy but can have a significant impact on quality of life. To allow cholecystostomy tube removal, percutaneous metallic stent placement was performed across the cystic duct via the tube tract in such a patient. The procedure included traversal across the previously placed CBD stent. At 5-month follow-up, the patient remained symptom-free. In select patients who develop acute cholecystitis after CBD stent placement for malignant obstruction, percutaneous stent placement across the cystic duct may be considered a treatment option.
Sheiman
Robert G
RG
Departments of Radiology, Beth Israel Deaconess Medical Center and Harvard Medical School, 330 Brookline Avenue, Boston, MA 02215, USA. rsheiman@caregroup.harvard.edu
Stuart
Keith
K
D000208:Acute Disease; D000230:Adenocarcinoma / Q000150:complications; D002764:Cholecystitis / Q000209:etiology* / Q000628:therapy*; D002779:Cholestasis / Q000209:etiology / Q000628:therapy*; D003135:Common Bile Duct; D003549:Cystic Duct; D005260:Female; D006801:Humans; D008875:Middle Aged; D010190:Pancreatic Neoplasms / Q000150:complications; D015607:Stents